Reneuron Group plc

Activities: Research & Development

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    How CDMOs can set a new gold standard when it comes to going green Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards...
  3. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  4. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Finance

ReNeuron and Fosun Pharma join forces in China

For exclusive rights to its CTX and hRPC cell therapy programmes, ReNeuron will receive £6 million upfront, and approximately £80 million in milestone payments
Manufacturing

ReNeuron to use Cellmate automated cell culture for stem cell-based stroke therapy

Accelerates production at new Advanced Therapy Medicinal Products manufacturing facility in Wales
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Delivering biotech therapies at scale

Biopharmaceutical production is changing rapidly and investment in new facilities is at an all time high. Susan Birks looks at some of the challenges involved in scaling up for commercial production across the range of products – from large molecule-based active ingredients to the latest stem cell therapies
Research & Development

ReNeuron and Cell Therapy Catapult announce collaboration

Will focus on CTX stem cell line of ReNeuron and develop new manufacturing technologies and assays
Subscribe now